Category: Legislative

GOP Returns to Power: How the 2024 Election Outcomes Could Affect the 340B Program

November 7, 2024 Shannon Young, Associate Editor/Senior Writer Views

Former President Donald Trump's (R) victory in Tuesday’s presidential election could have significant implications for the 340B program.

Former President Donald Trump’s victory over Democratic Vice President Kamala Harris in Tuesday’s presidential election capped a series of high-profile [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

November 5 is Finally Here: How the 2024 Elections Could Affect the 340B Program

November 5, 2024 Shannon Young, Associate Editor/Senior Writer Views

Voters will cast ballots in Tuesday's presidential contest between Vice President Kamala Harris (D) and former President Donald Trump (R).

When voters across the U.S. cast their ballots in Tuesday’s elections, they will not just be deciding who will control [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Pfizer CEO Calls 340B ‘One of the Biggest Issues’ During Earnings Call Touting $17.1B in Quarterly Revenue

October 31, 2024 William Newton, Associate Editor/Senior Writer Views

Pfizer CEO Albert Bourla told investors that "340B reform is something that myself and the entire pharma [industry] is setting as a priority."

Pfizer’s top executive told investors this week that the 340B program “is one of the biggest issues,” during an earnings [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Former Presidential Candidate Howard Dean Calls for More 340B Transparency, Declines to Discuss Op-ed, Alleged Drug Industry Ties

October 29, 2024 Shannon Young, Associate Editor/Senior Writer Views

Howard Dean urged federal lawmakers in an Oct. 25 RealClearHealth op-ed to pay attention to the 340B program.

A high-profile former Vermont governor with reported drug industry ties took aim at hospitals’ use of 340B savings, calling for [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Group That Does Not Disclose Its Funding Releases White Paper Calling for 340B Reforms, Advocates Slam Report

October 24, 2024 Shannon Young, Associate Editor/Senior Writer Views

The Health Equity Collaborative called for 340B program overhauls in a new white paper.

An organization that describes itself as being “comprised of dozens of national, public health, patient advocacy and multicultural organizations,” but [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

340B Lobbying Activity Did Not Slow Down in Q3, Federal Filings Suggest

October 22, 2024 Shannon Young, Associate Editor/Senior Writer Views

More than 360 firms reported lobbying on the 340B program between July 1 and Sept. 30.

The 340B drug discount program continued to be a hot topic for lobbyists in the third quarter of 2024, keeping [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Dark Money Poured Nearly $4M into Super PAC Opposing State 340B Contract Pharmacy Access Bills

October 18, 2024 William Newton, Associate Editor/Senior Writer Views

Stand for US PAC received $3.8 million in contributions over the last three months from a conservative dark money group.

A political action committee (PAC) that funded efforts opposing state 340B contract pharmacy access bills through misleading claims linking the [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Arkansas Begins Enforcement Against AstraZeneca for Allegedly Violating Contract Pharmacy Access Law

October 3, 2024 William Newton, Associate Editor/Senior Writer Views

The Arkansas Insurance Department held a preliminary hearing with attorneys for AstraZeneca on Oct. 1.

Arkansas officials initiated enforcement proceedings earlier this week against AstraZeneca for allegedly violating a state law that prohibits drugmaker 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Federal Judge Upholds Louisiana’s 340B Contract Pharmacy Law in Another Major Blow to Drug Industry

September 30, 2024 William Newton, Associate Editor/Senior Writer Views

A federal court upheld Louisiana’s contact pharmacy law this week, drawing praise from provider groups and criticism from the drug industry in the latest of such challenges across the nation.

A federal judge moments ago dismissed three drug industry challenges to Louisiana’s 340B contract pharmacy access law in another major [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

High-Ranking HRSA Official Talks Genesis Decision, Drugmaker Audits During Rare Unscripted Q&A at Industry Conference

September 26, 2024 William Newton, Associate Editor/Senior Writer Views

Lisa Scholz interviewed HRSA's OPA Director Chantelle Britton at the MDRP Summit in Chicago.

A high-ranking federal regulator addressed the 340B patient definition and manufacturer audits during an unscripted Q&A session after a speech [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Category: Legislative

GOP Returns to Power: How the 2024 Election Outcomes Could Affect the 340B Program

Please Login or Become a Paid Subscriber to View this Content

If you are already a

November 5 is Finally Here: How the 2024 Elections Could Affect the 340B Program

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Pfizer CEO Calls 340B ‘One of the Biggest Issues’ During Earnings Call Touting $17.1B in Quarterly Revenue

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Former Presidential Candidate Howard Dean Calls for More 340B Transparency, Declines to Discuss Op-ed, Alleged Drug Industry Ties

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Group That Does Not Disclose Its Funding Releases White Paper Calling for 340B Reforms, Advocates Slam Report

Please Login or Become a Paid Subscriber to View this Content

If you are already a

340B Lobbying Activity Did Not Slow Down in Q3, Federal Filings Suggest

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Dark Money Poured Nearly $4M into Super PAC Opposing State 340B Contract Pharmacy Access Bills

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Arkansas Begins Enforcement Against AstraZeneca for Allegedly Violating Contract Pharmacy Access Law

Please Login or Become a Paid Subscriber to View this Content

If you are already a

News Alert

Federal Judge Upholds Louisiana’s 340B Contract Pharmacy Law in Another Major Blow to Drug Industry

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Exclusive

High-Ranking HRSA Official Talks Genesis Decision, Drugmaker Audits During Rare Unscripted Q&A at Industry Conference

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

News Alert

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Exclusive

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Site Footer Live